Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.84
-0.1750-4.36%
Post-market: 3.870.0350+0.91%16:46 EDT
Volume:19.68M
Turnover:76.65M
Market Cap:2.05B
PE:-3.75
High:4.05
Open:4.01
Low:3.82
Close:4.01
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:0.49
T/O Rate:3.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:2.24
PE(LYR):-2.66

Loading ...

Movement Alert|Recursion Pharmaceuticals, Inc. Intraday Decline 8.02%, Tempus AI Agreement Restructuring and Insider Selling Fuel Market Divergence

Market Focus
·
Oct 12

Recursion, General Mills, Star Bulk, Lennar, Hershey Insider Shocks

TIPRANKS
·
Oct 10

Movement Alert|Recursion Pharmaceuticals, Inc. Rises 8.1% in Regular Trading, Partnership Adjustment and Insider Selling Spur Divergence

Market Focus
·
Oct 09

Movement Alert|Recursion Pharmaceuticals, Inc. Falls 8.08% in Regular Trading, Insider Selling and Amended Tempus AI Agreement Weigh on Sentiment

Market Focus
·
Oct 08

Top Recursion Pharma Insider Makes a Major Move With His Shares

TIPRANKS
·
Oct 08

Cathie Wood’s ARK Investment buys 1.9M shares of Recursion Pharmaceuticals today

TIPRANKS
·
Oct 08

Recursion Director Robert Hershberg Sells 25,000 Common Shares for $125,000

Reuters
·
Oct 08

Movement Alert|Recursion Pharmaceuticals, Inc. Falls 8.21% in Regular Trading, Tempus Data License Amendment Spurs Market Divergence

Market Focus
·
Oct 08

Cathie Wood’s ARK Investment buys 1.5M shares of Recursion Pharmaceuticals today

TIPRANKS
·
Oct 06

NASD Most Active Issues

Dow Jones
·
Oct 06

Could Tempus RNA License Alter The Investment Case For Recursion Pharmaceuticals (RXRX)?

Simply Wall St.
·
Oct 03

One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model

AI Industry Frontlines
·
Oct 03

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell
·
Oct 02

From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot

Tech News Roundup
·
Oct 02

Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal

Reuters
·
Sep 22

Tempus Extends Data Licensing Partnership with Recursion Through November 2029

Reuters
·
Sep 22

Tempus AI, Recursion Extend Data License, Amend Fee Structure

MT Newswires Live
·
Sep 21

Recursion, Tempus Expand AI and RNA Collaboration Agreements

TIPRANKS
·
Sep 21

Tempus AI, Recursion extend data license agreement, enter new license agreement

TIPRANKS
·
Sep 21

Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm

THOMSON REUTERS
·
Sep 21